Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Webinars / 2016 / Scalable suspension culture of human pluripotent stem cells – Controlling expansion and cardiomyogenic differentiation
Manufacture Facilities & Equipment Technology & Manufacturing

Scalable suspension culture of human pluripotent stem cells – Controlling expansion and cardiomyogenic differentiation

To harness the potential of human pluripotent stem cells (hPSCs), we need to achieve efficient scale-up.

08/01/2016

Sponsored By

Share


View on Demand

csm_TMM-webinar_main_06d02b494a.png

To harness the potential of human pluripotent stem cells (hPSCs), we need to achieve efficient scale-up. Here, our experts describe how hPSC expansion as matrix-independent aggregates in suspension culture (3D) was successfully combined with cardiomyogenic differentiation, and discuss the latest tools and technologies for scaling-up hPSC cultures and achieving controlled cultivation.

Visit Our Webinar Hub

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

More Webinars

Bioprocessing Business & Trends

November 15, 2016

Successful risk mitigation in biomanufacturing

Bioprocessing Business & Trends

November 15, 2016

In your bioprocessing journey, media matter

Keeping an eye on the supply chain horizon.

Recommended

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.